Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group (Q33501938)
Appearance
scientific article published on March 1, 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group |
scientific article published on March 1, 1998 |
Statements
1 reference
Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer Group (English)
1 reference
E. L. Sievers
B. J. Lange
P. M. Sondel
M. D. Krailo
J. Gan
W. Liu-Mares
1 March 1998
1 reference
1 reference
914-919
1 reference
Identifiers
1 reference
1 reference